Drawing for HY-TISSUE MICROGRAFT TECHNOLOGY

USPTO serial 79310677

HY-TISSUE MICROGRAFT TECHNOLOGY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MAGIT, JACOB FLEMING
Law office
TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HY-TISSUE MICROGRAFT TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; blood plasma; anticoagulants, diagnostic preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes; food for babies; dietary supplements for humans and animals; plasters, materials for dressings; material for stopping teeth and for dental impressions; disinfectants; fungicides; medicines; medical preparations for the prevention, control, therapy or mitigation of a disease or wound; dermocosmetic preparations for medicinal or surgical purposes; dermatological preparations; dermatological preparations for the treatment and care of chronic ulcers; dermal tissues for the treatment of burns; tissues or gauzes impregnated with antibacterial substances; pharmaceutical creams and lotions; creams, sprays, lotions, gels or ointments for dermatological purposes, wound care and tissue repair; nutraceutical preparations for use as dietary supplements; mineral, vitamin, dietary and nutritional supplements; nutritional dietary supplements; protein dietary supplements; mineral and vitamin food supplements; vitamins and minerals for medical or veterinary purposes; food additives for veterinary or medical purposes; nutritional and dietetic additives for veterinary or medical purposes; antioxidants, vitamins, mineral or oligo-elements as single or associated ingredients for the preparation of foodstuffs or nutritional supplements; parapharmaceutical preparations for dermatological useACTIVE—
010Medical and veterinary devices; medical and surgical, medical and veterinary apparatus and instruments; diagnostic apparatus for medical, cosmetic and veterinary purposes; apparatus and instruments for separating human and animal tissues and cells; devices for disaggregation of biological material for preparing cell suspensions and micro-insert of tissue; apparatus and instruments used in laboratories of microbiology for the processing of biological material; medical laboratory equipment for processing tissue samples; medical devices for the care of diseases concerning human tissues and for veterinary medicine; blood testing apparatus; cannulas; catheters; diagnostic devices for medical purposes; hemocytometers; hypodermic syringes; injectors for medical use; injection needles; syringes for injection; glass tubes for medical purposes; centrifuges for medical use; kits comprising apparatus for blood collection, separation of blood components, treatment of blood and reinjection of blood for medical purposes; orthopedic articles; suture materials; applicators and devices for the administration of pharmaceutical, cosmetic and dermocosmetic products for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 9, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 14, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 14, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 7, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 19, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 19, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 14, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 14, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 14, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 30, 2021RFNTREFUSAL PROCESSED BY IB—
Oct 1, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 30, 2021RFRRREFUSAL PROCESSED BY MPU—
Sep 15, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 14, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2021DOCKASSIGNED TO EXAMINER—
May 21, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
May 17, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 13, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance